These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38878112)

  • 1. Otud6b induces pulmonary arterial hypertension by mediating the Calpain-1/HIF-1α signaling pathway.
    Liu Y; Tang B; Wang H; Lu M
    Cell Mol Life Sci; 2024 Jun; 81(1):258. PubMed ID: 38878112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain-1 mediates vascular remodelling and fibrosis via HIF-1α in hypoxia-induced pulmonary hypertension.
    Deng H; Tian X; Sun H; Liu H; Lu M; Wang H
    J Cell Mol Med; 2022 May; 26(10):2819-2830. PubMed ID: 35365973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of 2-Methoxyestradiol and Sex on Hypoxia-Induced Pulmonary Hypertension and Hypoxia-Inducible Factor-1-α.
    Docherty CK; Nilsen M; MacLean MR
    J Am Heart Assoc; 2019 Mar; 8(5):e011628. PubMed ID: 30819028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.
    Johns RA; Takimoto E; Meuchel LW; Elsaigh E; Zhang A; Heller NM; Semenza GL; Yamaji-Kegan K
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):134-44. PubMed ID: 26586659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?
    Nie X; Shen C; Tan J; Wu Z; Wang W; Chen Y; Dai Y; Yang X; Ye S; Chen J; Bian JS
    Circ Res; 2020 Oct; 127(9):1138-1152. PubMed ID: 32752980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension.
    Barnes EA; Ito R; Che X; Alvira CM; Cornfield DN
    Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L741-L755. PubMed ID: 37847687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of smooth muscle cell hypoxia inducible factor-1α underlies increased vascular contractility in pulmonary hypertension.
    Barnes EA; Chen CH; Sedan O; Cornfield DN
    FASEB J; 2017 Feb; 31(2):650-662. PubMed ID: 27811062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT6 inhibits hypoxia-induced pulmonary arterial smooth muscle cells proliferation via HIF-1α/PDK4 signaling.
    Li M; Ying M; Gu S; Zhou Z; Zhao R
    Life Sci; 2023 Jan; 312():121192. PubMed ID: 36396113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal regulation of HIF-1α and 15-LO/15-HETE promotes anti-apoptosis process in pulmonary artery smooth muscle cells during hypoxia.
    Yao L; Nie X; Shi S; Song S; Hao X; Li S; Zhu D
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):96-106. PubMed ID: 22982617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.
    Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
    Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
    Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
    Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
    Cheng CC; Chi PL; Shen MC; Shu CW; Wann SR; Liu CP; Tseng CJ; Huang WC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.
    Ball MK; Waypa GB; Mungai PT; Nielsen JM; Czech L; Dudley VJ; Beussink L; Dettman RW; Berkelhamer SK; Steinhorn RH; Shah SJ; Schumacker PT
    Am J Respir Crit Care Med; 2014 Feb; 189(3):314-24. PubMed ID: 24251580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
    Zhang X; Qin H; Ma Q; Zhang J; Tian H; Meng Y
    Clin Respir J; 2024 May; 18(5):e13771. PubMed ID: 38747117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
    Bonnet S; Michelakis ED; Porter CJ; Andrade-Navarro MA; Thébaud B; Bonnet S; Haromy A; Harry G; Moudgil R; McMurtry MS; Weir EK; Archer SL
    Circulation; 2006 Jun; 113(22):2630-41. PubMed ID: 16735674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.